Evicenter
P&T meetings

Tinlarebant (LBS-008)

Stargardt disease type 1

Manufacturer
Belite Bio
Regulatory submission
NDA submitted June 2026
Last updated
66 sources

Product information and disease descriptionPlace of product in therapyDisease description

Diagnosis

4 evidence topics · 5 sources

Anticipated diagnostic testing

“ABCA4 Test” (opens the source at this quote in a new tab)

“Confirmatory test expected” (opens the source at this quote in a new tab)

Clinical and molecular diagnostic assessment

“Dilated eye exam, photos or scans of the retina, genetic testing” (opens the source at this quote in a new tab)

ABCA4-associated disease in childhood and adolescence

“ABCA4-associated disease in childhood and adolescence” (opens the source at this quote in a new tab)

“Only four patients revealed a definitely decreased autofluorescence in the macula.” (opens the source at this quote in a new tab)

Mesopic microperimetry in Stargardt disease: application and reliability

“Mesopic microperimetry in Stargardt disease: Application and reliability” (opens the source at this quote in a new tab)

“Mesopic microperimetry (mMP) is a promising functional endpoint in clinical trials for Stargardt disease type 1 (STGD1).” (opens the source at this quote in a new tab)